You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
通化金馬(000766.SZ):小金丸中標中成藥省際聯盟集中帶量採購
格隆匯 12-29 15:50

格隆匯12月29日丨通化金馬(000766.SZ)公佈,2021年12月,公司全資子公司成都永康製藥有限公司(簡稱“永康製藥”)參加了由中成藥省際聯盟集採領導小組辦公室(簡稱“集採辦公室”)組織的中成藥省際聯盟集中帶量採購的投標工作。根據集採辦公室2021年12月27日發佈的《中成藥省際聯盟集中帶量採購中選結果表》,永康製藥產品小金丸中標該次集中採購。

中選價格:28.28元/盒;供應省區:湖北、河北、山西、內蒙古、遼寧、福建、江西、河南、湖南、海南、重慶、四川、貴州、西藏、陝西、甘肅、寧夏、新疆、新疆生產建設兵團。採購週期:原則上2年,協議每年一簽。

小金丸是公司全資子公司永康製藥的主導品種,該品種2020年度合計銷售額約為1.49億元,佔公司營業收入的13.42%,佔永康製藥2020年度營業收入比例為75.94%。2021年前三季度合計銷售額約為1.54億元,佔公司2021年前三季營業收入的14.22%,佔永康製藥2021年前三季度營業收入比例為83.75%。

該次永康製藥中選價格與原基準價格相比雖然有一定幅度下降,但對於擴大市場銷售,增加產品銷量,提高小金丸的市場佔有率,通過增量提升效益,通過市場打造品牌的影響力,同時為公司進一步提升以小金丸為核心產品的產業鏈具有中長期的正面影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account